Further evidence showed that many different types of human tumors express high levels of IDO expression including 100% of prostatic, colorectal, pancreatic, cervical, and endometrial carcinomas, with 90% of GBM specimens expressing variable levels of IDO (Uyttenhove et al., 2003). The gene discussed is IDO1; the disease is endometrial carcinoma.